2026 Restricted Stock Incentive Plan Self-Examination Form

✨ AI Summary

This document serves as a self-examination form for the 2026 Restricted Stock Incentive Plan of Hangzhou Baicheng Pharmaceutical Technology Co., Ltd. It confirms compliance with various regulatory requirements, including the establishment of a performance assessment system and the absence of significant legal violations. Key compliance checks indicate that the plan does not exceed 20% of the company's total equity and that all necessary disclosures have been made.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Company Name: Hangzhou Baicheng Pharmaceutical Technology Co., Ltd.

Stock Code: 301096

No.	Item	Exists (Yes/No/Not Applicable)
1	Has the financial report for the most recent accounting year received a negative opinion or an inability to express an opinion from the auditor?	No
2	Has the internal control of the financial report for the most recent accounting year received a negative opinion or an inability to express an opinion from the auditor?	No
3	Has there been any instance in the last 36 months of profit distribution not conducted in accordance with laws, regulations, company articles, or public commitments?	No
4	Are there any other circumstances that make equity incentives inappropriate?	No
5	Has a performance assessment system and assessment methods been established?	Yes
6	Have loans or any other forms of financial assistance been provided to the incentive objects?	No

Compliance Requirements for Incentive Objects

No.	Item	Exists (Yes/No)
7	Does it include shareholders or actual controllers holding more than 5% of the company's shares, their spouses, parents, children, and foreign employees? If yes, is the necessity and reasonableness of including these individuals as incentive objects explained?	Yes
8	Does it include independent directors?	No
9	Has it been recognized as an inappropriate candidate by the stock exchange in the last 12 months?	No
10	Has it been recognized as an inappropriate candidate by the China Securities Regulatory Commission (CSRC) or its local agencies in the last 12 months?	No
11	Has it been subject to administrative penalties or market entry bans by the CSRC or its local agencies in the last 12 months due to major violations?	No
12	Does it have any circumstances that disqualify it from serving as a director or senior management as stipulated by the Company Law?	No
13	Are there any other circumstances that make it inappropriate to become an incentive object?	No
14	Has the incentive list been verified by the Compensation and Assessment Committee?	Yes

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.